Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicoletta Riva

Showing results (1-10 of 105) with videos related to

Pageof 11
Sort By:
Journal of Clinical Medicine|March 14, 2020
Cerebral and Splanchnic Vein Thrombosis: Advances, Challenges, and Unanswered QuestionsNicoletta Riva, Walter Ageno
Seminars in Thrombosis and Hemostasis|February 24, 2015
Pros and cons of vitamin K antagonists and non-vitamin K antagonist oral anticoagulantsNicoletta Riva, Walter Ageno
F1000Research|July 6, 2023
Bayesian subjectivism and psychosocial attitude toward COVID-19 vaccinesAlberto Zatti, Nicoletta Riva
Internal and Emergency Medicine|July 9, 2015
Direct oral anticoagulants in atrial fibrillation: can data from randomized clinical trials be safely transferred to the general population? YesNicoletta Riva, Walter Ageno
Thrombosis Research|July 5, 2017
Clinical manifestations and imaging tools in the diagnosis of splanchnic and cerebral vein thrombosesNicoletta Riva, Walter Ageno
Hamostaseologie|July 30, 2020
Head, Neck, and Abdominopelvic Septic Thrombophlebitis: Current Evidence and Challenges in Diagnosis and TreatmentLuca Valerio, Nicoletta Riva
Blood Transfusion = Trasfusione Del Sangue|April 7, 2015
Which patients with venous thromboembolism should receive non-vitamin K antagonist oral anticoagulants? The majorityNicoletta Riva, Walter Ageno
Behavioral Sciences (Basel, Switzerland)|April 26, 2025
Body Image, Autonomy, and Vaccine Hesitancy: A Psychodynamic Approach to Anti-Vaccine Individuals' ResistanceAlberto Zatti, Nicoletta Riva
Journal of Translational Internal Medicine|April 3, 2018
Timing of Anticoagulation for Portal Vein Thrombosis in Liver Cirrhosis: An Italian Internist's PerspectiveNicoletta Riva, Walter Ageno
Research and Practice in Thrombosis and Haemostasis|March 18, 2021
Direct oral anticoagulants for unusual-site venous thromboembolismNicoletta Riva, Walter Ageno
Pageof 11

Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
Journal of Clinical Medicine|March 14, 2020
Cerebral and Splanchnic Vein Thrombosis: Advances, Challenges, and Unanswered QuestionsNicoletta Riva, Walter Ageno
Seminars in Thrombosis and Hemostasis|February 24, 2015
Pros and cons of vitamin K antagonists and non-vitamin K antagonist oral anticoagulantsNicoletta Riva, Walter Ageno
F1000Research|July 6, 2023
Bayesian subjectivism and psychosocial attitude toward COVID-19 vaccinesAlberto Zatti, Nicoletta Riva
Internal and Emergency Medicine|July 9, 2015
Direct oral anticoagulants in atrial fibrillation: can data from randomized clinical trials be safely transferred to the general population? YesNicoletta Riva, Walter Ageno
Thrombosis Research|July 5, 2017
Clinical manifestations and imaging tools in the diagnosis of splanchnic and cerebral vein thrombosesNicoletta Riva, Walter Ageno
Hamostaseologie|July 30, 2020
Head, Neck, and Abdominopelvic Septic Thrombophlebitis: Current Evidence and Challenges in Diagnosis and TreatmentLuca Valerio, Nicoletta Riva
Blood Transfusion = Trasfusione Del Sangue|April 7, 2015
Which patients with venous thromboembolism should receive non-vitamin K antagonist oral anticoagulants? The majorityNicoletta Riva, Walter Ageno
Behavioral Sciences (Basel, Switzerland)|April 26, 2025
Body Image, Autonomy, and Vaccine Hesitancy: A Psychodynamic Approach to Anti-Vaccine Individuals' ResistanceAlberto Zatti, Nicoletta Riva
Journal of Translational Internal Medicine|April 3, 2018
Timing of Anticoagulation for Portal Vein Thrombosis in Liver Cirrhosis: An Italian Internist's PerspectiveNicoletta Riva, Walter Ageno
Research and Practice in Thrombosis and Haemostasis|March 18, 2021
Direct oral anticoagulants for unusual-site venous thromboembolismNicoletta Riva, Walter Ageno
Pageof 11